Stock Scorecard
Stock Summary for Immunocore Holdings plc (IMCR) - $35.27 as of 9/4/2025 1:41:27 PM EST
Total Score
11 out of 30
Safety Score
42 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for IMCR
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for IMCR
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for IMCR
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for IMCR
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for IMCR (42 out of 100)
| Stock Price Rating (Max of 10) | 8 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for IMCR
Financial Details for IMCR
Company Overview |
|
|---|---|
| Ticker | IMCR |
| Company Name | Immunocore Holdings plc |
| Country | USA |
| Description | Immunocore Holdings Limited, an advanced stage biotechnology company, develops immunotherapies for the treatment of cancer, infectious and autoimmune diseases. The company is headquartered in Abingdon, the United Kingdom. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 11/5/2025 |
Stock Price History |
|
| Last Day Price | 35.27 |
| Price 4 Years Ago | 34.24 |
| Last Day Price Updated | 9/4/2025 1:41:27 PM EST |
| Last Day Volume | 516,958 |
| Average Daily Volume | 311,315 |
| 52-Week High | 39.33 |
| 52-Week Low | 23.15 |
| Last Price to 52 Week Low | 52.35% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 27.24 |
| Sector PE | 40.17 |
| 5-Year Average PE | -15.91 |
| Free Cash Flow Ratio | 3.64 |
| Industry Free Cash Flow Ratio | 11.70 |
| Sector Free Cash Flow Ratio | 28.68 |
| Current Ratio Most Recent Quarter | 5.89 |
| Total Cash Per Share | 9.68 |
| Book Value Per Share Most Recent Quarter | 7.71 |
| Price to Book Ratio | 4.18 |
| Industry Price to Book Ratio | 43.13 |
| Sector Price to Book Ratio | 45.62 |
| Price to Sales Ratio Twelve Trailing Months | 4.56 |
| Industry Price to Sales Ratio Twelve Trailing Months | 30.35 |
| Sector Price to Sales Ratio Twelve Trailing Months | 11.64 |
| Analyst Buy Ratings | 9 |
| Analyst Strong Buy Ratings | 4 |
Share Statistics |
|
| Total Shares Outstanding | 50,387,000 |
| Market Capitalization | 1,777,149,490 |
| Institutional Ownership | 98.20% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 822.00% |
| Annual Earnings Growth | 7.60% |
| Reported EPS 12 Trailing Months | -0.41 |
| Reported EPS Past Year | -0.69 |
| Reported EPS Prior Year | -0.92 |
| Net Income Twelve Trailing Months | -20,312,000 |
| Net Income Past Year | -51,087,000 |
| Net Income Prior Year | -55,287,000 |
| Quarterly Revenue Growth YOY | 29.90% |
| 5-Year Revenue Growth | 64.61% |
| Operating Margin Twelve Trailing Months | -15.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 487,933,000 |
| Total Cash Past Year | 455,731,000 |
| Total Cash Prior Year | 442,626,000 |
| Net Cash Position Most Recent Quarter | 95,873,000 |
| Net Cash Position Past Year | 64,718,000 |
| Long Term Debt Past Year | 391,013,000 |
| Long Term Debt Prior Year | 48,011,000 |
| Total Debt Most Recent Quarter | 392,060,000 |
| Equity to Debt Ratio Past Year | 0.48 |
| Equity to Debt Ratio Most Recent Quarter | 0.50 |
| Total Stockholder Equity Past Year | 360,716,000 |
| Total Stockholder Equity Prior Year | 368,843,000 |
| Total Stockholder Equity Most Recent Quarter | 388,481,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 28,451,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.56 |
| Free Cash Flow Past Year | 20,888,000 |
| Free Cash Flow Prior Year | -2,485,000 |
Options |
|
| Put/Call Ratio | 16.53 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.30 |
| MACD Signal | -0.35 |
| 20-Day Bollinger Lower Band | 27.61 |
| 20-Day Bollinger Middle Band | 32.62 |
| 20-Day Bollinger Upper Band | 37.64 |
| Beta | 0.78 |
| RSI | 44.25 |
| 50-Day SMA | 31.51 |
| 150-Day SMA | 47.53 |
| 200-Day SMA | 44.51 |
System |
|
| Modified | 9/4/2025 2:10:50 AM EST |